Mixtard 30 HM 100IU/ml Penfill (3ml Each)

Mixtard 30 HM 100IU/ml Penfill (3ml Each) – Introduction

Mixtard 30 HM 100IU/ml Penfill (3ml Each) is a blend of two medications, incorporating an intermediate-acting and a short-acting form of insulin. It is prescribed for the management of diabetes mellitus (both type 1 and 2) to enhance blood sugar regulation in adults and children. The medication helps maintain appropriate blood sugar levels in individuals with diabetes.

How Mixtard 30 HM 100IU/ml Penfill (3ml Each) Works: A Closer Look

Mixtard 30 HM Penfill 100IU/ml (3ml Each) consists of a combination of two types of insulin: Insulin Isophane/NPH and Human Insulin/Soluble Insulin. Insulin Isophane/NPH offers an extended duration of action, whereas Human Insulin/Soluble Insulin has a rapid onset of action. When used together, they work to achieve swift and consistent control of blood sugar levels by promoting the uptake of sugar in muscle and fat cells and inhibiting the liver’s sugar production.

Use

Diabetes

Mixtard 30 HM 100IU/ml Penfill (3ml Each) – The Benefits

In Diabetes

Mixtard 30 HM 100IU/ml Penfill contains a combination of intermediate-acting and short-acting insulin varieties. Combined, they work together to achieve swift and consistent control of blood sugar levels throughout the day. Administered through injection, your doctor or nurse will guide you to the correct injection technique. Effectively managing blood glucose levels is a crucial aspect of diabetes care. By maintaining control over these levels, you can reduce the risk of developing severe complications associated with diabetes, such as kidney damage, eye issues, nerve problems, and limb loss. Regular use of this medication, a balanced diet, and exercise contribute to leading a healthy everyday life.

Mixtard 30 HM 100IU/ml Penfill (3ml Each) – A Usage Guide

This medication will be provided to you by your doctor or nurse, and it is essential not to self-administer.

Mixtard 30 HM 100IU/ml Penfill (3ml Each) – Side Effects

Most side effects typically do not necessitate medical intervention and tend to resolve as your body acclimates to the medication. If these side effects persist or cause concern, it is advisable to consult with your doctor.

Common Side Effects

• Hypoglycemia (low blood glucose level)
• Injection site reactions (pain, swelling, redness)
• Weight gain

[Note: Different drugs can cause varying side effects. To get accurate information about a medication’s specific side effects, refer to the official prescription information or consult your healthcare provider.]

Mixtard 30 HM 100IU/ml Penfill (3ml Each) – A Guide to Safety

Alcohol

Unsafe

It is not advisable to consume alcohol while using Mixtard 30 HM 100IU/ml Penfill (3ml Each) due to potential risks.

Pregnancy

Safe If Prescribed

Mixtard 30 HM 100IU/ml Penfill is typically deemed safe during pregnancy. While animal studies have demonstrated minimal or no harmful effects on the developing baby, there is limited data from human studies.

Breastfeeding

Safe If Prescribed

Mixtard 30 HM 100IU/ml Penfill (3ml Each) is considered safe during breastfeeding. According to human studies, the medication is unlikely to be passed into breast milk in substantial amounts, posing minimal risk to the nursing baby.

Driving

Caution

It may affect your ability to drive if you have signs of either high or low blood sugar. When experiencing such symptoms, refrain from driving.

Liver

Caution

Exercise caution when using Mixtard 30 HM 100IU/ml Penfill in individuals with liver disease, as dose adjustment may be required. Consult your doctor for guidance, and regular monitoring of glucose levels is advised to facilitate dose adjustments.

Kidney

Caution

Exercise caution when administering Mixtard 30 HM 100IU/ml Penfill (3ml Each) in individuals with kidney disease, as it may necessitate dose adjustment. Consult your doctor for advice, and regular monitoring of blood glucose levels is advisable for dose adjustment.

 Fact Box

Swift Advice

• Administer the insulin 15 minutes before or within 20 minutes after starting a meal.
• Opt for an abdominal injection for faster absorption compared to other sites, such as the upper arms, thighs, or buttocks. After injection, avoid massaging the injection site.
• Rotate injection sites to prevent the development of hard lumps at a single location.
• Switching to a different type or brand of insulin should be done under strict medical supervision, as it may require adjustments to the dosage.
• Hypoglycemia may occur when combining insulin with other antidiabetic medicines, alcohol, or when delaying/skipping a meal. Carry a sugar source for immediate relief.
• Do not share your insulin device, even if the needle has been changed, as it can lead to severe infections.
• Opened vials/cartridges remain viable at room temperature for up to four weeks, while unopened vials should be refrigerated (2°C–8°C).